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Quality of Life in Patients Undergoing Hemodialysis or 
Peritoneal Dialysis Treatment
Paraskevi Theofilou
Abstract
Background:  “Does the type of dialysis treatment make a differ-
ence to the quality of life (QoL) and mental health of renal patients 
in Athens?” The study investigated the differences in 84 in-center 
hemodialysis (HD) and 60 continuous ambulatory peritoneal dialy-
sis (CAPD/PD) patients.
Methods:    Patient-reported  assessments  included:  WHOQOL-
BREF  inventory  of World  Health  Organization,  General  Health 
Questionnaire  (GHQ-28)  of  Goldberg,  State-Trait  Anxiety 
Inνentory,  Center  for  Epidemiologic  Studies  Depression  Scale 
(CES-D) and Multidimensional Health Locus of Control (MHLC).
Results:  Results indicated that HD patients reported lower QoL in 
the environment and social relationships domains. More symptoms 
were also reported in the GHQ-28 subscales of anxiety/insomnia 
and severe depression. This measurement includes sleep problems 
and suicidal thoughts.
Conclusions:  The findings confirm the differences between the 
two treatment modalities, indicating that HD patients have poorer 
QoL in several aspects of their environment and their social rela-
tionships. Both groups reported elevated depression. However, HD 
patients reported more suicidal thoughts and sleep problems com-
pared to PD patients.
Keywords:  Quality of life; Hemodialysis; Peritoneal dialysis; Re-
nal disease
Introduction
Modern societies include increasing proportions of elderly 
people, with a resulting increase in the incidence and du-
ration of chronic illnesses. Similarly, advanced age is con-
sidered a significant determinant of depression [1] and poor 
quality of life (QoL) [2, 3]. Additionally, the provision of 
therapies relevant to chronic diseases addresses the issues 
beyond the concept of cure, bringing to the center the need 
for a dignified QoL of patients [4]. An increased interest in 
QoL is observed in patients who suffer from chronic diseas-
es, including those with end-stage renal disease [5, 6].
Regarding patients either in hemodialysis (HD) or con-
tinuous  ambulatory  peritoneal  dialysis  (CAPD/PD)  treat-
ment modalities, the QoL differences reported in the relevant 
literature, are inconclusive [7]. Generally, studies that exam-
ined generic QoL, have indicated that although global QoL 
levels are comparable between the two treatment categories, 
there  are  treatment-related  differences  in  dialysis-specific 
aspects of QoL, with some domains better for HD and oth-
ers better for PD group. For example, HD patients have re-
ported higher scores in measurements of physical well-being 
[8], including better sleep and sexual life [9]. Such evidence 
was seen in the first two years of dialysis and over a pe-
riod of time [9-11]. However, findings are mixed. Sleeping 
problems and distress during the night, before the dialysis, 
have been indicated by HD patients [12-15]. On the other 
hand, compromised physical well-being in CAPD patients 
has been reported in connection with lower levels of albumin 
[11] and health complications, e.g., peritonitis [16].
Regarding  mental  health,  HD  are  reported  to  present 
more depressive symptoms than PD patients [12, 17, 18]. 
Depression could be linked to the HD treatment requiring 
continuous connection with the hemodialysis machine and 
the patients experiencing serious restrictions on their level 
of independence [12, 17]. The rate of suicidal attempts in 
HD group is high, while a considerable number of deaths 
caused by dietary violations, may be also linked to suicide 
commitment [19, 20]. Furthermore, HD patients are reported 
to face psychosocial problems, e.g., conflictuous interactions 
with their medical carers. Such findings can be attributed to 
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the stressful conditions in the HD treatment modality, with 
frequent visits and prolonged waiting time in the HD unit 
[12, 21, 22].
It appears that psychological indicators tend to favor 
PD patients. This can be due to the PD treatment offering 
increased autonomy and control, flexibility in everyday life 
and reduction of dietary and social restrictions [10, 23-25]. 
Specifically, PD group has indicated better QoL ratings in 
‘perceived ability to travel’, ‘financial concerns’, ‘restric-
tion in eating and drinking’ and ‘dialysis access problems’ 
[9, 26]. Further on, PD patients have indicated more positive 
ratings in several kidney-disease QoL domains, e.g., kidney 
disease burden and encouragement satisfaction with medical 
care [27].
In overall, end-stage renal disease patients have to cope 
with many adversities, like physical symptoms, special diet 
schedules, changes in their body image while the outcome of 
treatment is not standard [28]. They also have to reconsider 
their personal, social and professional goals within the con-
text of living with chronic illness. End-stage renal disease is 
considered to have serious effects on the patients’ QoL and 
may affect negatively the social, financial and psychological 
aspects of their life [29-31].
The purpose of this study is to examine differences in 
QoL as well as mental health between HD and PD patients. 
We mainly hypothesize that HD patients present lower levels 
of QoL indicating more symptoms of depression and anxiety.
Materials and Methods
Participants  were  recruited  from  three  General  Hospitals 
in Athens. The sample included 84 patients undergoing in-
center  hemodialysis  (HD)  and  60  undergoing  continuous 
ambulatory peritoneal dialysis (CAPD). Most HD patients 
were male (a higher percentage of males is reported to suffer 
from chronic renal failure) [32], single, slightly younger than 
females and with less years of education.
The subjects (HD, PD) were selected according to the 
following criteria: 1) diagnosis of end-stage renal disease, 
2) current HD or PD treatment, 3) age above 18, 4) native 
language-Greek, and 5) volunteer participation and signed 
consent form.
All subjects had been informed of their rights to refuse 
or discontinue participation in the study, according to the 
ethical standards of the Helsinki Declaration of 1983. Ethi-
cal permission for the study was obtained from the scientific 
committees of the hospitals.
Measurement tools
World  Health  Organization  Quality  of  Life  instrument 
(WHOQOL–BREF) [33]
It is a self-report generic QoL inventory of 26 items, vali-
dated within Greek populations [34]. The items fall into 4 
domains: a) Physical health, b) Psychological well-being, c) 
Social Relationships, and d) Environment. Two of the items 
provide a facet measuring Overall QoL/health. It is rated on 
a 5-point Likert scale and the range of scores is between 1 
and 20 with higher scores indicating better QoL.
General Health Questionnaire (GHQ-28)
It is a widely used self-report measure of general health, de-
veloped by Goldberg [35], and validated with Greek popu-
lations [36]. It may identify short-term changes in mental 
health and is often used as a screening instrument for psychi-
atric cases in medical setting and general practice. The 28-
item version used in this study, consists of four sub-scales: 
a) somatic symptoms, b) anxiety/insomnia, c) social dys-
function, and d) severe depression. Higher scores indicate a 
worse general health status.
Table  1.  Sociodemographic  Characteristics  of  the 
Sample (N = 144)
HD
N = 84 (58.3%)
PD
N = 60 (41.7%)
Age (years)
Mean (SD)
58.12 (16.11) 64.28 (12.51)
Gender
    Male  55 (65.5%) 31 (51.7%)
    Female 29 (34.5%) 29 (48.3%)
    Total 84 (100.0%) 60 (100.0%)
Marital status
    Single 19 (22.6%) 6 (10.0%)
    Married 58 (69.0%) 49 (81.7%)
    Divorced 1 (1.2%) 0 (0%)
    Widowed 6 (7.1%) 4 (6.7%)
    Roommate 0 (0%) 1 (1.7%)
    Total 84 (100.0%) 60 (100.0%)
Education
    Elementary 42 (50.0%) 20 (33.3%)
    Secondary 26 (31.0%) 30 (50.0%)
    University 16 (19.0%) 10 (16.7%)
    Total 84 (100.0%) 60 (100.0%)
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State-Trait Anxiety Inνentory (STAI 1/STAI 2)
It consists of 20 items referring to self-reported state anxi-
ety and 20 items to trait anxiety [37, 38]. State anxiety re-
flects a “transitory emotional state or condition of the human 
organism  that  is  characterized  by  subjective,  consciously 
perceived feelings of tension and apprehension, and height-
ened autonomic nervous system activity”; it may fluctuate 
over time and can vary in intensity. In contrast, trait anxiety 
denotes “relatively stable individual differences in anxiety 
proneness” and refers to a general tendency to respond with 
anxiety to perceived threats in the environment [37]. Higher 
scores mean that patients are more anxious.
Center for Epidemiologic Studies Depression Scale (CES-D) 
[39-41]
It is a 20-item self-report measure of depression. A higher 
score  means  that  the  patient  is  more  depressed. A  value 
above 9.03 is required for a subject to be classified as de-
pressed [41].
Multidimensional Health Locus of Control (MHLC)
It is a self-report tool measuring health behavior in terms of 
internal beliefs about the current condition of health. The in-
ventory consists of 18 items, which comprise 4 categories of 
beliefs: a) internal locus, b) chance, c) doctors, and d) impor-
tant others. The last three refer to external locus of control 
[42, 43]. The 4 categories are not mutually exclusive and 
scores may weight in a particular direction. Higher scores in-
dicate stronger presence of the specific dimension of beliefs.
 
Results
The  total  sample  of  144  patients  consisted  of  86  males 
(59.7%) and 58 females (40.3%), with a mean age of 60.6 
Table 3. Mean Scores ± SD of GHQ-28 Health Subscales (Independent-Samples T Test Showing 
Differences Between HD and PD Patients)
* P < 0.05; N = 144
GHQ-28 subscales
HD Patients (N = 84) PD Patients (N = 60)
P-value
Mean ± SD Mean ± SD
Somatic symptoms 1.86 ± 0.55 1.69 ± 0.52 0.06
Anxiety/insomnia 1.88 ± 0.65 1.48 ± 0.58 0.00*
Social dysfunction 2.30 ± 0.51 2.21 ± 0.40 0.25
Severe depression 1.58 ± 0.77 1.30 ± 0.56 0.02*
Total score 1.90 ± 0.50 1.67 ± 0.44 0.01*
Table 2. Mean Scores ± SD of WHOQOL-BREF Domains and the Overall QoL/Health Facet (Independent-Samples 
T Test Demonstrating Differences Between HD and PD Patients)
* P < 0.05; N = 144
WHOQOL-BREF domains
HD Patients (N = 84) PD Patients (N = 60)
P-value
Mean ± SD Mean ± SD
Physical  12.71 ± 3.70 13.70 ± 2.96 0.08
Psychological  13.26 ± 3.65 13.36 ± 3.14 0.86
Social relationships 12.89 ± 3.51 14.03 ± 2.43 0.02*
Environment 13.00 ± 2.71 14.52 ± 1.78 0.00*
Overall QoL/health 3.00 ± 1.07 3.15 ± 0.82 0.34
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years. Descriptive statistics are presented in Table 1. HD pa-
tients were receiving current dialysis treatment for a mean 
duration of 7.3 ± 7.1 years, while PD patients for 3.2 ± 2.0 
years. There were 9 missing values due to information miss-
ing from the patients’ medical records.
The values of the two groups were found to pass the 
normality distribution test. HD indicated lower QoL scores 
in the domains of environment and social relationships (P < 
0.05) (Table 2). Further, they reported higher scores in the 
GHQ-28 sub-scales of anxiety/insomnia (P < 0.05), severe 
depression (P < 0.05), and in the total GHQ-28 score (Table 
3).
However,  no  statistically  significant  differences  were 
found between the two groups in the independent scales of 
depression with CES-D and anxiety with STAI 1 & 2 (Table 
4). It is noteworthy that following further analysis in order to 
detect depression in individual cases (with the use of cut-off 
points presented earlier in the instruments’ section), both HD 
and PD have values that are above the suggested level and 
are thus considered depressed (M = 12.43 and 13.26) [41].
As far as internal beliefs, both groups presented simi-
lar patterns, with internal being the major locus of control, 
followed by chance, then by doctors and last by important 
others. However, some differences were also identified: HD 
presented comparatively higher scores in the dimension of 
internal locus, which can be indicative of a relatively stron-
ger belief of their own control over their current condition 
of health. On the other hand, PD presented higher scores in 
the dimension of doctors, perhaps indicating a comparative-
ly stronger belief of the control of their medical carers over 
their current condition of health and treatment (Table 5).
Discussion
  
The results of the study provide support regarding expected 
QoL and mental health differences between the two treatment-
modality groups. Patients in the HD treatment, compared to 
PD treatment patients, reported a more compromised QoL 
in the domains of environment and social relationships. Ac-
cordingly, the HD group indicated experiencing less support 
from their community and social relationships. This may be 
Table 4. Mean Scores ± SD of Depression and State-Trait Anxiety (Independent-Samples T 
Test Showing Differences Between HD and PD Patients)
Table 5. Mean Scores ± SD of Health Locus of Control Factors (Independent-Samples T Test Showing Differ-
ences Between HD and PD Patients)
N = 144
* P < 0.05; N = 144
CES-D
HD Patients (N = 84) PD Patients (N = 60)
P-value
Mean ± SD Mean ± SD
Depression 12.43 ± 13.63 13.26 ± 10.40 0.74
STAI 1
State Anxiety 29.68 ± 11.12 30.63 ± 8.92 0.66
STAI 2
Trait Anxiety 35.15 ± 8.96 35.50 ± 9.35 0.87
Health Locus of Control factors
HD Patients (N = 84) PD Patients (N = 60)
P-value 
Mean ± SD Mean ± SD
Internal locus 26.89 ± 6.85 24.17 ± 8.11 0.03*
Chance 24.62 ± 8.22 22.84 ± 9.06 0.23
Doctors 16.00 ± 2.59 17.01 ± 1.61 0.00*
Important others 12.39 ± 4.44 12.19 ± 4.70 0.79
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associated with the restrictions imposed on their lives and 
the dependence on the dialysis procedure, which may cause 
social isolation [15, 26]. Also, it may be associated with the 
continuous  stressful  conditions  governing  HD  treatment, 
e.g., high frequency of received in-center treatment and pro-
longed waiting-time in the medical unit [12, 21, 22].
Furthermore, HD compared to PD patients, indicated 
more problems in different aspects of their environment with 
a more negative evaluation, including availability/quality of 
health services, transportation, finances, recreation and op-
portunities for acquiring new skills and knowledge.
Regarding  mental  health,  HD  patients  were  found  to 
evaluate less favorably their overall health status, reporting 
more physical and psychological symptoms, such as anxi-
ety, sleeping problems and suicidal thoughts. It is notewor-
thy that both groups were considered depressed according 
to their values in the CES-D scale [41]. The higher levels 
of depression and anxiety in the GHQ sub-scales were not 
observed in the independent scales of CES-D and STAI 1. A 
possible explanation may be that different aspects of depres-
sion are measured by different instruments. Subsequently, 
the GHQ severe depression subscale includes items about 
suicidal thoughts, which are not measured by the CES-D 
scale. The comparatively higher scoring of HD patients on 
a scale that examines suicidal thoughts is in agreement with 
higher rates of suicidal attempts reported in this group [18-
20].
Similarly, the GHQ anxiety/insomnia and STA1 scales 
do not measure the same content (e.g., items on sleep prob-
lems are not included in the latter scale).
Findings in the relevant literature regarding self-report-
ed physical and psychological well-being, are mixed. In sev-
eral studies, HD reported better scores than PD on physical 
well-being [8]. Similarly, prospective studies have shown 
a more favourable effect of HD treatment on physical QoL 
over time [9].
Regarding  internal  beliefs  about  current  condition  of 
health, both groups are comparable presenting a similar pat-
tern, that is scoring higher in the dimension of internal locus, 
which is followed by the dimensions of chance, doctors and 
important others. A difference between the two treatment 
modalities concerns the relatively higher values of the HD 
patients in internal locus, indicating probably the emphasis 
on their own behavior for control over their current condi-
tion of health, perhaps a counterbalance for feelings of de-
pendence on the machine. On the contrary, PD seemed to 
give more importance to the function of doctors, probably 
because they need to be trained in peritoneal dialysis pro-
cedures with the help of medical professionals. These find-
ings may have also a relevance to the previously mentioned 
higher level of state anxiety in early starters of PD treatment.
In  overall,  there  is  evidence  supporting  that  patients 
in HD treatment were in a more compromised position in 
comparison to PD. Social relationships and perceptions of 
environment, including health services, seemed to suffer. In 
terms of mental health, HD patients reported more anxiety/
insomnia, depressive and suicidal symptoms. Regarding lo-
cus of control about current condition of health, both groups 
seemed to follow comparable patterns, while a difference 
was observed over the weight of each group on internal and 
external control.
Regarding  limitations,  patients  were  recruited  from 
three different renal units and were a convenience sample. 
Thus, it was not possible for the two patient groups to be 
well-matched for demographic variables. Also, patients var-
ied with respect to the length of current treatment, and the 
analysis of differences for this variable was performed post-
hoc. Further, due to missing information in the patients’ re-
cords, there were some missing values for the latter variable. 
The data also of this study are cross-sectional and therefore 
do not provide insight into the longitudinal effects of current 
dialysis treatment on QoL and mental health. Finally, evi-
dence provided by the results of this study can be extended 
by the control of the above issues and the use of even larger 
samples.
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